Register Login

All Posts

In vitro detection and removal of DOACs from patient plasma specimens

Announcing a 9-30-20 open access publication [forgive the self-reference]: McGlasson DL, Fritsma, GA. In vitro detection and removal of direct oral anticoagulants from patient plasma specimens. Annals of Blood 2020:doi: 10.21037/aob-20-16. We describe a urine DOAC Dipstick and several competing “filter” devices that remove DOACs from plasma, enabling the operator to perform clot-based [PT and […]
read more

October 2020 Quick Question: Inflammation

Our October Quick Question is selected from the many open questions we received during our September 15 webinar. “Covid-Associated Coagulopathy: A Conversation about Controversies and Confusion” [click] featuring Andrew Goodwin, MD, CLIA Medical Director, University of Vermont Medical Center and Laboratory Services and Section Medical Director of the Thrombosis and Hemostasis Laboratory. In our Quick […]
read more

Sept, 2020 Quick Question Reponse: Fibrinolysis

Here are our responses to the September, 2020 Quick Question, wich attracted 51 participants. How does your facility measure fibrinolysis? Plasminogen: 3 [5%] Tissue plasminogen activator [TPA]: 1 [2%] Plasminogen activator inhibitor 1 [PAI-1]: 1 [2%] Thromboelastograph [TEG]: 10 [20%] Rotational thromboelastometry [ROTEM]: 36 [71%] As we speculated the first three measures of fibrinolysis are […]
read more